Spero Oncology Overview
- Founded
-
2014

- Status
-
Acquired/Merged
- Employees
-
11

- Latest Deal Type
-
M&A
- Financing Rounds
-
1
Spero Oncology General Information
Description
Operator of a clinical research organization (CRO) focused on development of oncology products. The company provides clinical operations support for oncology clinical trials primarily throughout Europe, but also in Australia and New Zealand.
Contact Information
Website
www.spero-oncology.com
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Decision/Risk Analysis
Other Industries
Laboratory Services (Healthcare)
Pharmaceuticals
Acquirer
Primary Office
- Duart House 3 Finch Way
- Strathclyde Business Park
- Bellshill ML4 3PR
- Scotland, United Kingdom
Spero Oncology Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Spero Oncology Executive Team (3)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Theresa Bruce | Founder & Managing Director | ||
Kathryn Clayton | Director, Clinical Operations | ||
Grace Flynn | Director, Contracts & Proposals |